Skip to main content
SpringerLink
Log in

Findings of MIBG Cardiac Scintigraphy: Dementia with Lewy Bodies and Related Dementia

  • Chapter
  • First Online:
Clinical Assessment of the Autonomic Nervous System

  • 1338 Accesses

Abstract

Dementia with Lewy bodies (DLB) is the second most common neurodegenerative form of dementia. The core features of DLB include progressive cognitive decline, parkinsonism, autonomic failure, and sleep disorders. Because the symptoms are similar between DLB and Alzheimer’s disease (AD), it is often difficult to make a definitive diagnosis, in particular, during the early course of the illness. Cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphy is one of the most useful tools for differentiating DLB from AD. DLB patients generally show markedly reduced cardiac MIBG uptake, regardless of the presence of parkinsonism. This finding is consistent with pathological findings of cardiac sympathetic nerve involvement in DLB. However, patients with AD, corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), and vascular dementia (VaD) generally show normal cardiac MIBG uptake. Therefore, MIBG cardiac scintigraphy provides a powerful method for early differentiation of DLB from other forms of dementia, with equal or superior diagnostic capabilities when compared to dopamine transporter imaging or perfusion/metabolic imaging. Recent studies have demonstrated that most subjects with rapid eye movement (REM) sleep behavior disorder (RBD) progressing to DLB or Parkinson’s disease (PD) during long follow-up periods also have abnormal cardiac MIBG uptake. Thus, MIBG cardiac scintigraphy may have the potential to detect prodromal DLB before obvious cognitive and functional changes are observed. This procedure could more accurately identify early dementia and could enhance the development and use of disease-modifying therapies for DLB.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Watanabe H, Ieda T, Katayama T, Takeda A, Aiba I, Doyu M, et al. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2001;70(6):781–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer’s-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2001;71(5):583–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, et al. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer’s disease and dementia with Lewy bodies. Intern Med. 2003;42(8):686–90.

    Article  PubMed  Google Scholar 

  4. Hanyu H, Shimizu S, Hirao K, Kanetaka H, Iwamoto T, Chikamori T, et al. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer’s disease. Eur J Nucl Med Mol Imaging. 2006;33(3):248–53.

    Article  PubMed  Google Scholar 

  5. Hanyu H, Shimizu S, Hirao K, Sakurai H, Iwamoto T, Chikamori T, et al. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Dement Geriatr Cogn Disord. 2006;22(5–6):379–84.

    Article  PubMed  Google Scholar 

  6. Kashihara K, Ohno M, Kawada S, Okumura Y. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson’s disease and dementia with Lewy bodies. J Nucl Med. 2006;47(7):1099–101.

    CAS  PubMed  Google Scholar 

  7. Suzuki M, Kurita A, Hashimoto M, Fukumitsu N, Abo M, Ito Y, et al. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson’s disease. J Neurol Sci. 2006;240(1–2):15–9.

    Article  CAS  PubMed  Google Scholar 

  8. Yoshita M, Taki J, Yokoyama K, Noguchi-Shinohara M, Matsumoto Y, Nakajima K, et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology. 2006;66(12):1850–4.

    Article  CAS  PubMed  Google Scholar 

  9. Inui Y, Toyama H, Manabe Y, Sato T, Sarai M, Kosaka K, et al. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT. J Nucl Med. 2007;48(10):1641–50.

    Article  PubMed  Google Scholar 

  10. Wada-Isoe K, Kitayama M, Nakaso K, Nakashima K. Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study. J Neurol Sci. 2007;260(1–2):33–7.

    Article  PubMed  Google Scholar 

  11. Estorch M, Camacho V, Paredes P, Rivera E, Rodriguez-Revuelto A, Flotats A, et al. Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging. 2008;35(9):1636–41.

    Article  PubMed  Google Scholar 

  12. Novellino F, Bagnato A, Salsone M, Cascini GL, Nicoletti G, Arabia G, et al. Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD. Neurobiol Aging. 2010;31(11):1903–11.

    Article  PubMed  Google Scholar 

  13. Oka H, Yoshioka M, Morita M, Onouchi K, Suzuki M, Ito Y, et al. Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease. Neurology. 2007;69(14):1460–5.

    Article  CAS  PubMed  Google Scholar 

  14. Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005;109(6):583–8.

    Article  PubMed  Google Scholar 

  15. Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin JJ, et al. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. Int J Geriatr Psychiatry. 2014;42:1239–50.

    Google Scholar 

  16. Marquie Sayagues M, Da Silva AL, Molina-Porcel L, Alcolea Rodriguez D, Sala Matavera I, Sanchez-Saudinos MB, et al. (123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia. Neurologia. 2010;25(7):414–21.

    Article  CAS  PubMed  Google Scholar 

  17. Treglia G, Cason E. Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging. 2012;22(2):111–7.

    Article  PubMed  Google Scholar 

  18. Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, et al. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS ONE. 2015;10(3):e0120540.

    Article  PubMed  PubMed Central  Google Scholar 

  19. O’Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, et al. Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials. BMJ Open. 2014;4(7):e005122.

    Article  PubMed  PubMed Central  Google Scholar 

  20. McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6(4):305–13.

    Article  PubMed  Google Scholar 

  21. Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Rainer M, et al. Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study. Br J Psychiatry. 2015;206(2):145–52.

    Article  PubMed  Google Scholar 

  22. Treglia G, Cason E, Cortelli P, Gabellini A, Liguori R, Bagnato A, et al. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? J Neuroimaging. 2014;24(2):149–54.

    Article  PubMed  Google Scholar 

  23. Camacho V, Marquie M, Lleo A, Alves L, Artigas C, Flotats A, et al. Cardiac sympathetic impairment parallels nigrostriatal degeneration in probable dementia with Lewy bodies. Q J Nucl Med Mol Imaging. 2011;55(4):476–83.

    CAS  PubMed  Google Scholar 

  24. Tateno M, Kobayashi S, Shirasaka T, Furukawa Y, Fujii K, Morii H, et al. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2008;26(5):453–7.

    Article  PubMed  Google Scholar 

  25. Inui Y, Toyama H, Manabe Y, Sarai M, Iwata N. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer’s disease. Ann Nucl Med. 2014;28(8):796–804.

    Article  CAS  PubMed  Google Scholar 

  26. Oda H, Ishii K, Terashima A, Shimada K, Yamane Y, Kawasaki R, et al. Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies. Neurology. 2013;81(20):1741–5.

    Article  PubMed  Google Scholar 

  27. Fava GA, Kellner R. Prodromal symptoms in affective disorders. Am J Psychiatry. 1991;148(7):823–30.

    Article  CAS  PubMed  Google Scholar 

  28. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22(2):353–70.

    Article  CAS  PubMed  Google Scholar 

  29. Fujishiro H, Iseki E, Nakamura S, Kasanuki K, Chiba Y, Ota K, et al. Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics. 2013;13(2):128–38.

    Article  PubMed  Google Scholar 

  30. Iranzo A, Tolosa E, Gelpi E, Molinuevo JL, Valldeoriola F, Serradell M, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol. 2013;12(5):443–53.

    Article  PubMed  Google Scholar 

  31. Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain J Neurol. 2012;135(Pt 6):1860–70.

    Article  CAS  Google Scholar 

  32. Postuma RB, Gagnon JF, Pelletier A, Montplaisir J. Prodromal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord Off J Mov Disord Soc. 2013;28(5):597–604.

    Article  Google Scholar 

  33. Iranzo A, Gelpi E, Tolosa E, Molinuevo JL, Serradell M, Gaig C, et al. Neuropathology of prodromal Lewy body disease. Mov Disord Off J Mov Disord Soc. 2014;29(3):410–5.

    Article  Google Scholar 

  34. Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67(12):2236–8.

    Article  CAS  PubMed  Google Scholar 

  35. Miyamoto T, Miyamoto M, Iwanami M, Hirata K. Idiopathic REM sleep behavior disorder: implications for the pathogenesis of Lewy body diseases. Park Dis. 2011;2011:941268.

    Google Scholar 

  36. Miyamoto T, Orimo S, Miyamoto M, Hirata K, Adachi T, Hattori R, et al. Follow-up PET studies in case of idiopathic REM sleep behavior disorder. Sleep Med. 2010;11(1):100–1.

    Article  PubMed  Google Scholar 

  37. Chiaravalloti A, Stefani A, Di Biagio D, Pierantozzi M, Tavolozza M, Di Pietro B, et al. Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson’s disease. Ann Nucl Med. 2013;27(5):444–51.

    Article  PubMed  Google Scholar 

  38. Sakakibara R, Ogata T, Haruta M, Kishi M, Tsuyusaki Y, Tateno A, et al. Amnestic mild cognitive impairment with low myocardial metaiodobenzylguanidine uptake. Am J Neurodegener Dis. 2012;1(2):146–51.

    PubMed  PubMed Central  Google Scholar 

  39. Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50(3):358–65.

    Article  CAS  PubMed  Google Scholar 

  40. Holtbernd F, Gagnon JF, Postuma RB, Ma Y, Tang CC, Feigin A, et al. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014;82(7):620–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Brain and Mind Research Center, Nagoya University Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan

    Hirohisa Watanabe

  2. Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan

    Gen Sobue

Authors
  1. Hirohisa Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gen Sobue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hirohisa Watanabe .

Editor information

Editors and Affiliations

  1. Department of Phyisiology, Aichi Medical University, Nagakute, Aichi, Japan

    Satoshi Iwase

  2. Nagoya City University, Graduate School of Medical Science, Nagoya, Japan

    Junichiro Hayano

  3. Department of Neurology, Kanto Central Hospital, Tokyo, Tokyo, Japan

    Satoshi Orimo

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan

About this chapter

Cite this chapter

Watanabe, H., Sobue, G. (2017). Findings of MIBG Cardiac Scintigraphy: Dementia with Lewy Bodies and Related Dementia. In: Iwase, S., Hayano, J., Orimo, S. (eds) Clinical Assessment of the Autonomic Nervous System. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56012-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56012-8_16

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56010-4

  • Online ISBN: 978-4-431-56012-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation